- Home
- PRTA vs ABSI Comparison
PRTA vs ABSI Comparison
Compare PRTA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ABSI
- Stock Information
- Founded
- PRTA 2012
- ABSI 2011
- Country
- PRTA Ireland
- ABSI United States
- Employees
- PRTA N/A
- ABSI N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- PRTA Health Care
- ABSI Health Care
- Exchange
- PRTA Nasdaq
- ABSI Nasdaq
- Market Cap
- PRTA 472.1M
- ABSI 338.0M
- IPO Year
- PRTA N/A
- ABSI 2021
- Fundamental
- Price
- PRTA $8.20
- ABSI $2.39
- Analyst Decision
- PRTA Buy
- ABSI Strong Buy
- Analyst Count
- PRTA 10
- ABSI 5
- Target Price
- PRTA $14.86
- ABSI $7.98
- AVG Volume (30 Days)
- PRTA 1.2M
- ABSI 4.4M
- Earning Date
- PRTA 08-04-2025
- ABSI 08-12-2025
- Dividend Yield
- PRTA N/A
- ABSI N/A
- EPS Growth
- PRTA N/A
- ABSI N/A
- EPS
- PRTA N/A
- ABSI N/A
- Revenue
- PRTA $10,341,000.00
- ABSI $4,138,000.00
- Revenue This Year
- PRTA N/A
- ABSI $44.71
- Revenue Next Year
- PRTA $389.77
- ABSI $374.26
- P/E Ratio
- PRTA N/A
- ABSI N/A
- Revenue Growth
- PRTA N/A
- ABSI 27.32
- 52 Week Low
- PRTA $4.32
- ABSI $2.01
- 52 Week High
- PRTA $22.83
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- ABSI 33.33
- Support Level
- PRTA $8.05
- ABSI $2.50
- Resistance Level
- PRTA $8.73
- ABSI $2.73
- Average True Range (ATR)
- PRTA 0.38
- ABSI 0.18
- MACD
- PRTA -0.05
- ABSI -0.04
- Stochastic Oscillator
- PRTA 47.62
- ABSI 1.94
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.